• Tomivosertib: Mechanistic Insights and Protocols for MNK1 In

  2026-06-22

  Explore how Tomivosertib, a potent MNK1 inhibitor, advances cancer research by modulating the MNK-eIF4E signaling pathway. This article delivers practical protocols, mechanistic depth, and a unique focus on angiogenesis and chemoresistance.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-06-22

  This study demonstrates that activating ALDH2 prolongs the proliferative window of cardiomyocytes in mice and delays the onset of heart failure following ventricular pressure overload. The findings establish ALDH2 as a critical regulator of cardiac regeneration, offering mechanistic insights for future therapeutic strategies targeting heart failure.

• Applied Strategies for ABT-888 (Veliparib) in DNA Repair Inh

  2026-06-21

  ABT-888 (Veliparib) empowers oncology researchers to dissect DNA repair mechanisms and optimize combination cancer therapies in models with microsatellite instability. This guide translates recent insights and experimental best practices into actionable workflows, troubleshooting, and advanced use-cases, maximizing the impact of PARP inhibition in preclinical research.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Advanced Use-Cas

  2026-06-20

  The One-step TUNEL Cy5 Apoptosis Detection Kit empowers researchers with highly sensitive, streamlined detection of apoptotic DNA fragmentation in both tissue sections and cultured cells. Its Cy5-based fluorescence system enables robust quantification and visualization, making it indispensable for advanced programmed cell death research and resistance mechanism studies.

• Vancomycin: Glycopeptide Antibiotic for MRSA & C. difficile

  2026-06-19

  Vancomycin’s precise D-Ala-D-Ala binding empowers advanced resistance and microbiome studies, with robust protocols for MRSA and Clostridium difficile models. This guide translates validated workflows and troubleshooting strategies into actionable steps—ensuring reliable results for antibacterial research.

• Berberine Hydrochloride Expands Tuft Cells to Counter Bone L

  2026-06-19

  This study uncovers that berberine ameliorates estrogen deficiency-associated bone loss by inducing intestinal tuft cell expansion via a butyrate-GPR41 pathway. The findings highlight a novel gut-bone immunometabolic axis, offering new mechanistic insight and experimental directions for postmenopausal osteoporosis and osteoimmune research.

• TP53 and DNA Damage Pathways Modulate Calicheamicin ADC Sens

  2026-06-18

  A recent genome-wide CRISPR/Cas9 screening study reveals that TP53, ATM, and MDM2 are critical modulators of acute leukemia cell sensitivity to calicheamicin-based antibody–drug conjugates (ADCs). These findings provide mechanistic insight into resistance and suggest actionable targets for combination therapies to improve ADC efficacy.

• ABT-888 (Veliparib): Optimizing DNA Repair Inhibition Workfl

  2026-06-18

  ABT-888 (Veliparib) unlocks new possibilities in colorectal and ovarian cancer research by precisely targeting PARP-mediated DNA repair. This guide details actionable protocols, advanced applications, and troubleshooting strategies for maximizing the translational power of this PARP inhibitor in chemo- and radiosensitization studies.

• Müller Cell PEDF and Angiopoietin Signaling in Retinal Neuro

  2026-06-17

  This study demonstrates that Müller cell-derived pigment epithelium-derived factor (PEDF) is a critical mediator of angiopoietin-dependent survival of retinal neurons. By elucidating the distinct roles of Ang-1 and Ang-2 in regulating Tie-2 signaling and PEDF production, the research advances understanding of neurovascular interactions relevant for retinal neuroprotection and anti-angiogenic strategies.

• Maternal Deltamethrin Impairs Offspring Memory via p53-Ferro

  2026-06-17

  This study demonstrates that maternal exposure to deltamethrin during pregnancy and lactation causes learning and memory deficits in male rat offspring through a p53-mediated ferroptosis pathway in the hippocampus. These findings clarify a mechanistic link between environmental neurotoxicant exposure and neurodevelopmental dysfunction, with significant implications for the use of p53 inhibitors in neurotoxicity research.

• DiR (DiIC 18 (7)) Transforms Membrane Imaging Workflows

  2026-06-16

  DiR (DiIC 18 (7)) merges deep-red sensitivity and long-term stability to redefine cell and tissue membrane tracking in both in vitro and in vivo settings. Explore how this near-infrared probe, from APExBIO, elevates tracking accuracy, optimizes neuronal tracing, and streamlines advanced imaging protocols.

• I-BET151 (GSK1210151A): BET Inhibitor Protocols and Best Pra

  2026-06-16

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor used to modulate transcriptional programs in cancer biology, notably in apoptosis and cell cycle arrest assays. It is not intended for diagnostic or therapeutic applications and requires careful attention to solubility and workflow setup for reproducible results.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor in EMT Rese

  2026-06-15

  LY364947, a selective TGF-β type I receptor kinase inhibitor from APExBIO, empowers researchers to dissect epithelial-mesenchymal transition (EMT) and fibrosis with precision. This guide details advanced workflows, troubleshooting strategies, and actionable insights that maximize experimental reliability across cellular and in vivo models.

• Nose-to-Brain Delivery of Rotigotine Nanoparticles in PD Mod

  2026-06-15

  This study demonstrates that chitosan nanoparticle-based intranasal delivery of Rotigotine significantly improves neuroprotection and brain targeting in cellular and animal models of Parkinson’s disease. These findings highlight a promising approach for overcoming the bioavailability limitations of dopamine D2/D3 receptor agonists in neurodegenerative disease research.

• JNK-IN-7: Selective JNK Inhibitor for Precision Pathway Stud

  2026-06-14

  JNK-IN-7 delivers unparalleled selectivity and covalent inhibition for dissecting MAPK, apoptosis, and innate immune pathways. This guide translates recent breakthroughs and best practices into actionable workflows, empowering researchers to achieve more reliable and interpretable results in inflammation and cell death models.

16270 records 1/1085 page Next 12345 下5页 Last page